Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems. Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.
Subscribe to see VITRAFY LIFE SCIENCES LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
VITRAFY LIFE SCIENCES LIMITED is a pharmaceuticals, biotechnology & life sciences company headquartered in Melbourne, Australia. It is publicly listed (VFY) with a market capitalisation of $237.6M. Xcout tracks 1 named person at VITRAFY LIFE SCIENCES LIMITED, including Jeannie Joughin (Non-Executive Director).
As of 16 November 2026. Source: Xcout Intel.
A few of VITRAFY LIFE SCIENCES LIMITED's closest competitors — see the full list of competitors and alternatives →
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Shenzhen Cellbri Bio-Innovation Technology, founded in 2020 and headquartered in Shenzhen, develops and manufactures scalable solutions and closed-loop systems for the cell and gene therapy industry.
Bio-Thera Solutions is a Canadian biotechnology company that builds manufacturing infrastructure for extracellular vesicles, producing and characterizing exosomes at scale for research and industry partners. The company supplies EV material and licenses its technology exclusively to a skincare partner for cosmetic applications, while also researching therapeutic uses such as dermatology, tissue repair, and drug delivery.
Mytos is a biotechnology research and automation company headquartered in London, United Kingdom. Its automation technology enables faster cell culture scaling and cleanroom batch production at a lower cost.
ChainReactor Technologies provides infrastructure for industrial biology by combining physical AI, process engineering, and patented advanced manufacturing. The company offers modular benchtop bioreactors and a large biological model to help biomanufacturers predict cell behavior and test processes at scale before commercial production.
Asahi Kasei Life Science Corp. focuses on bioprocess and life science businesses, including the development, manufacture, and sale of virus removal filters such as Planova for biotherapeutics manufacturing.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about VITRAFY LIFE SCIENCES LIMITED? Suggest a correction · Work at VITRAFY LIFE SCIENCES LIMITED? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.